Tabula Rasa Health Care, Inc. TRHC
We take great care to ensure that the data presented and summarized in this overview for Tabula Rasa HealthCare, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in TRHC
Top Purchases
Top Sells
About TRHC
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2021, it served approximately 150 healthcare organizations; and 350 health plans and approximately 18,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
Insider Transactions at TRHC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 03
2023
|
Ronald Paul Mitchell |
SELL
Sale (or disposition) back to the issuer
|
Direct |
79,332
-61.28%
|
-
|
Nov 03
2023
|
Michael J. Purcell |
SELL
Sale (or disposition) back to the issuer
|
Direct |
139,322
-81.77%
|
-
|
Nov 03
2023
|
Pamela Schweitzer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
9,784
-100.0%
|
-
|
Nov 03
2023
|
Pamela Schweitzer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
79,220
-83.82%
|
-
|
Nov 03
2023
|
Jonathan David Schwartz |
SELL
Sale (or disposition) back to the issuer
|
Direct |
78,388
-61.21%
|
-
|
Nov 03
2023
|
Dennis Helling |
SELL
Sale (or disposition) back to the issuer
|
Direct |
112,109
-62.21%
|
-
|
Nov 03
2023
|
Michael Anthony Bruno CHIEF ACCOUNTING OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,955
-76.08%
|
-
|
Nov 03
2023
|
Thomas Cancro CHIEF FINANCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
304,092
-52.12%
|
-
|
Nov 03
2023
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
586,984
-45.12%
|
-
|
Nov 03
2023
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
767,311
-44.98%
|
-
|
Nov 03
2023
|
Richard W. Rew Ii CHIEF LEGAL OFFICER, SECRETARY |
SELL
Sale (or disposition) back to the issuer
|
Direct |
63,657
-70.0%
|
-
|
Nov 03
2023
|
Indaba Capital Management, L.P. Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
6,599,966
-100.0%
|
$65,999,660
$10.5 P/Share
|
Nov 03
2023
|
Samira Beckwith |
SELL
Sale (or disposition) back to the issuer
|
Direct |
88,299
-85.48%
|
-
|
Nov 03
2023
|
Kathrine O'Brien |
SELL
Sale (or disposition) back to the issuer
|
Direct |
96,689
-62.59%
|
-
|
Jun 28
2023
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
14,194
-3.74%
|
$99,358
$7.69 P/Share
|
Jun 28
2023
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+6.18%
|
$75,000
$3.11 P/Share
|
Jun 28
2023
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
25,647
-5.13%
|
$179,529
$7.69 P/Share
|
Jun 28
2023
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
42,153
+7.77%
|
$126,459
$3.11 P/Share
|
Jun 09
2023
|
Indaba Capital Management, L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
25,641
+0.39%
|
-
|
Jun 09
2023
|
Pamela Schweitzer |
BUY
Grant, award, or other acquisition
|
Direct |
25,641
+24.45%
|
-
|